Efficacy of Filgotinib, a Selective jak1 Inhibitor, is Independent of Prior Anti-TNF Exposure: Subgroup Analysis of the Phase 2 Fitzroy Study in Moderate-To-Severe Crohn’s Disease

Saved in:

Bibliographic Details
Published in	Gastroenterology (New York, N.Y. 1943) Vol. 152; no. 5; p. S597
Main Authors	D'Haens, Geert R, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A, Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T, Van der Aa, Annegret, Harrison, Pille, Vermeire, Severine
Format	Journal Article
Language	English
Published	01.04.2017
Subjects	Gastroenterology and Hepatology
Online Access	Get full text
ISSN	0016-5085
DOI	10.1016/S0016-5085(17)32136-4

More Information
ISSN:	0016-5085
DOI:	10.1016/S0016-5085(17)32136-4